Abstract
The 2014 joint meeting of the International Society for Cellular Oncology (ISCO) and the European Workshop on Cytogenetics and Molecular Genetics of Solid Tumors (EWCMST), organized by Nick Gilbert, Juan Cigudosa and Bauke Ylstra, was held from 11 to 14 May in Malaga, Spain. Since the previous meeting in 2012, the ever increasing availability of new sequencing technologies has enabled the analysis of cancer genomes at an increasingly greater detail. In addition to structural changes in the genome (i.e., translocations, deletions, amplifications), frequent mutations in important regulatory genes have been found to occur, as also frequent alterations in a large number of epigenetic factors. The challenge now is to relate structural changes in cancer genomes to the underlying disease mechanisms and to reveal opportunities for the design of novel (targeted) therapies. During the meeting, various topics related to these challenges and opportunities were addressed, including those dealing with functional genomics, genome instability, biomarkers and diagnostics, cancer genetics and epigenomics. Special attention was paid to therapy-driven cancer evolution (keynote lecture) and relationships between DNA repair, cancer and ageing (Prof. Ploem lecture). Based on the information presented at the meeting, several aspects of the cancer genome and its functional implications are provided in this report.
References
A. Geurts van Kessel, New insights and advancements in cellular oncology. Cell. Oncol. 35, 139–147 (2012)
F. Supek, B. Minana, J. Valcarcel, T. Gabaldon, B. Lehner, Synonymous mutations frequently act as driver mutations in human cancers. Cell 156, 1324–1335 (2014)
J.J. Gartner, S.C.J. Parker, T.D. Prickett, K. Dutton-Regester, M.L. Stitzel, J.C. Lin, S. Davis, V.L. Simhadri, S. Jhaf, N. Katagiri, V. Gotea, J.K. Teer, X. Wei, M.A. Morken, U.K. Bhanot, NISC Comparative Sequencing Program, G. Chen, L.L. Elnitski, M.A. Davies, J.E. Gershenwald, H. Carter, R. Karchin, W. Robinson, S. Robinson, S.A. Rosenberg, F.S. Collins, G. Parmigiani, A.A. Komar, C. Kimchi-Sarfaty, N.K. Hayward, E.H. Margulies, Y. Samuels, Whole-genome sequencing identifies a recurrent functional synonymous mutation in melanoma. Proc. Natl. Acad. Sci. U. S. A. 110, 13481–13486 (2013)
V.K. Hill, J.J. Gartner, Y. Samuels, A.M. Goldstein, The genetics of melanoma: recent advances. Ann. Rev. Gen. Hum. Genet. 14, 257–279 (2013)
G. Evan, Taking the backdoor to target Myc. Science 335, 293–294 (2012)
Z. Nie, G. Hu, G. Wei, K. Cui, A. Yamane, W. Resch, R. Wang, D.R. Green, L. Tessarollo, R. Casellas, K. Zhao, D. Levens, c-Myc Is a universal amplifier of expressed genes in lymphocytes and embryonic stem cells. Cell 151, 68–79 (2012)
C.Y. Lin, J. Loven, P.B. Rahl, R.M. Paranal, C.B. Burge, J.E. Bradner, T.I. Lee, R.A. Young, Transcriptional amplification in tumor cells with elevated c-Myc. Cell 151, 56–67 (2012)
A. Sabò, B. Amati, Genome recognition by MYC. Cold. Spring. Harb. Perspect. Med. 4, (2014). doi: 10.1101/cshperspect.a014191
H. Clevers, E. Battle, Snapshot: the intestinal crypt. Cell 152, 1198.e1 (2013)
W.H. Liu, N. You, N. Zhang, H.T. Yan, T. Wang, Z. Huang, H.B. Liu, L.J. Tang, Interpretation of interlocking key issues of cancer stem cells in malignant solid tumors. Cell. Oncol. 35, 397–409 (2012)
M.D. Hale, J.D. Hayden, H.I. Grabsch, Tumour-microenvironment interactions: role of tumour stroma and proteins produced by cancer-associated fibroblasts in chemotherapy reponse. Cell. Oncol. 36, 95–112 (2013)
M. Kraman, P.J. Bambrough, J.N. Arnold, E.W. Roberts, L. Magiera, J.O. Jones, A. Gopinathan, D.A. Tuveson, D.T. Fearon, Suppression of antitumor immunity by stromal cells expressing fibroblast activating protein-alpha. Science 330, 827–830 (2010)
A. Calon, E. Espinet, S. Palomo-Ponce, D.V.F. Tauriello, M. Iglesias, M. Virtudes Céspedes, M. Sevillano, C. Nadal, P. Jung, X.H.F. Zhang, D. Byrom, A. Riera, D. Rossell, R. Mangues, J. Massague, E. Sancho, E. Batlle, Dependency of colorectal cancer on a TGF-beta-driven programme in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012)
A. Calona, D.V.F. Taurielloa, E. Batlle, TGF-beta in CAF-mediated tumor growth and metastasis. Sem. Cancer Biol. 25, 15–22 (2014)
N.A. Ajoub, A.D. Devaprasath, J.A. Bernal, A.R. Venkitaraman, HP1-beta mobilization promotes chromatin changes that initiate the DNA damage response. Nature 453, 682–686 (2008)
M.J. Garnett, J. Mansfeld, C. Godwin, T. Matsusaka, J. Wu, P. Russell, J. Pines, A.R. Venkitaraman, UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit. Nature Cell Biol. 11, 1363–1369 (2009)
A.D. Jeyasekharan, Y. Liu, H. Hattori, V. Pisupati, A.B. Jonsdottir, E. Rajendra, M. Lee, E. Sundaramoorthy, S. Schlachter, C. Kaminski, Y. Rosenfeld, K. Sato, J. Savill, N. Ayoub, A.R. Venkitaraman, A cancer-associated BRCA2 mutation reveals masked nuclear export signals controlling localization. Nature Struct. Mol. Biol. 20, 1191–1198 (2013)
H. Liang, A. Esposito, P. Collin, U. Surana, A.R. Venkitaraman, Homeostatic control in G2 checkpoint fidelity and timing. Nature Commun. 5, 4048 (2014). doi:10.1038/ncomms5048
E. Yiannakopoulou, Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications. Cell. Oncol. 37, 1–8 (2014)
A.R. Venkitaraman, Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 343, 1470–1475 (2014)
S. Remeseiro, A. Cuadrado, A. Losada, Cohesin in development and disease. Development 140, 3715–3718 (2013)
D.A. Solomon, T. Kim, L.A. Diaz-Martinez, J. Fair, A.G. Elkahloun, B.T. Harris, J.A. Toretsky, S.A. Rosenberg, N. Shukla, M. Ladanyi, Y. Samuels, C.D. James, H. Yu, J.S. Kim, T. Waldman, Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science 333, 1039–1043 (2011)
S. Remeseiro, A. Cuadrado, G. Gomez-Lopez, D.G. Pisano, A. Losado, A unique role of cohesion-SA1 in gene regulation and development. EMBO J. 31, 2090–2102 (2012)
J.S. Welch, T.J. Ley, D. Link, C.A. Miller, D.E. Larson, D.C. Koboldt, L.D. Wartman, T. Lamprecht, F. Liu, J. Xia, C. Kandoth, R.S. Fulton, M.D. McLellan, D.J. Dooling, J.W. Wallis, K. Chen, C.C. Harris, H.K. Schmidt, J.M. Kalicki-Veizer, C. Lu, Q. Zhang, L. Lin, M.D. O’Laughlin, J.F. McMichael, K.D. Delehaunty, L.A. Fulton, V.J. Magrini, S.D. McGrath, R.T. Demeter, T.L. Vickery, J. Hundal, L.L. Cook, G.W. Swift, J.P. Reed, P.A. Alldredge, T.N. Wylie, J.R. Walker, M.A. Watson, S.E. Heath, W.D. Shannon, N. Varghese, R. Nagarajan, J.E. Payton, J.D. Baty, S. Kulkarni, J.M. Klco, M.H. Tomasson, P. Westervelt, M.J. Walter, T.A. Graubert, J.F. DiPersio, L. Ding, E.R. Mardis, R.K. Wilson, The origin and evolution of mutations in acute myeloid leukemia. Cell 150, 264–275 (2012)
D.W. Schoppy, R.L. Ragland, O. Gilad, N. Shastri, A.A. Peters, M. Murga, O. Fernandez-Capetillo, J.A. Diehl, E.J. Brown, Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR. J. Clin. Invest. 122, 242–252 (2012)
A. Alentorn, H.F. van Thuijl, Y. Marie, H. Alshehhi, C. Carpentier, B. Boisselier, F. Laigle-Donadey, K. Mokhtari, I. Scheinin, P. Wesseling, B. Ylstra, L. Capelle, K. Hoang-Xuan, M. Sanson, J.Y. Delattre, J.C. Reijneveld, A. Idbaih, Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas. Neuro. Oncol. 16, 400–408 (2014)
M. di Pietro, R.C. Fitzgerald, Research advances in esophageal diseases: bench to bedside. F1000Prime Rep. 5, 44 (2013). doi:10.12703/P5-44
P. Bus, P.D. Siersema, J.W.P.M. van Baal, Cell culture models for studying the development of Barrett’s esophagus: a systematic review. Cell. Oncol. 35, 149–161 (2012)
A.M. Dulak, P. Stojanov, S. Peng, M.S. Lawrence, C. Fox, C. Stewart, S. Bandla, Y. Imamura, S.E. Schumacher, E. Shefler, A. McKenna, S.L. Carter, K. Cibulskis, A. Sivachenko, G. Saksena, D. Voet, A.H. Ramos, D. Auclair, K. Thompson, C. Sougnez, R.C. Onofrio, C. Guiducci, R. Beroukhim, Z. Zhou, L. Lin, J. Lin, R. Reddy, A. Chang, R. Landrenau, A. Pennathur, S. Ogino, J.D. Luketich, T.R. Golub, S.B. Gabriel, E.S. Lander, D.G. Beer, T.E. Godfrey, G. Getz, A.J. Bass, Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nature Genet. 45, 478–486 (2013)
P.L. Bedard, A.R. Hansen, M.J. Ratain, L.L. Siu, Tumour heterogeneity in the clinic. Nature 501, 355–364 (2013)
E. Waanders, B. Scheijen, S. van Reijmersdal, T. van der Meer, L. van Emst, Y. Kroeze, E. Sonneveld, P.M. Hoogerbrugge, A. Geurts van Kessel, F.N. van Leeuwen, R.P. Kuiper, The origin and nature of tightly clustered BTG1 deletions in precursor B-cell acute lymphoblastic leukemia support a model of multiclonal evolution. PloS Genet. 8, e1002533 (2012)
P. Ulivi, R. Silvestrini, Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer. Cell. Oncol. 36, 439–448 (2013)
L.H.A. Broersen, G.W. van Pelt, R.A.E.M. Tollenaar, W.E. Mesker, Clinical application of circulating tumor cells in breast cancer. Cell. Oncol. 37, 9–15 (2014)
F.X. Real, P.C. Boutros, N. Malats, Next-generation sequencing of urologic cancers: next is now. Eur. Urol. 66, 4–7 (2014)
The Cancer Genome Atlas Research Network, Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315–322 (2014)
N. Ganguly, Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value. Cell. Oncol. 35, 67–76 (2012)
G. Iye, A.J. Hanrahan, M.I. Milowsky, H. Al-Ahmadie, S.N. Scott, M. Janakiraman, M. Pirun, C. Sander, N.D. Socci, I. Ostrovnaya, A. Viale, A. Heguy, L. Peng, T.A. Chan, B. Bochner, D.F. Bajorin, M.F. Berger, B.S. Taylor, D.B. Solit, Genome sequencing identifies a basis for everolimus sensitivity. Science 338, 221 (2012)
M.D. Jones, E.K. Colvin, A.M. Nagrial, E.S. Humphrey, A. Chou, V.T. Chin, L.A. Chantrill, A. Mawson, J.S. Samra, J.G. Kench, J.A. Lovell, R.J. Daly, N.D. Merrett, C. Toon, K. Epari, N.Q. Nguyen, A. Barbour, N. Zeps, Australian Pancreatic Cancer Genome Initiative, N. Kakkar, F. Zhao, Y.Q. Wu, M. Wang, D.M. Muzny, W.E. Fisher, F.C. Brunicardi, S.E. Hodges, J.G. Reid, J. Drummond, K. Chang, Y. Han, L.R. Lewis, H. Dinh, C.J. Buhay, T. Beck, L. Timms, M. Sam, K. Begley, A. Brown, D. Pai, A. Panchal, N. Buchner, R. De Borja, R.E. Denroche, C.K. YungK, S. Serra, N. Onetto, D. Mukhopadhyay, M.S. Tsao, P.A. Shaw, G.M. Petersen, S. Gallinger, R.H. Hruban, A. Maitra, C.A. Iacobuzio-Donahue, R.D. Schulick, C.L. Wolfgang, R.A. Morgan, R.T. Lawlor, P. Capelli, V. Corbo, M. Scardoni, G. Tortora, M.A. Tempero, K.M. Mann, N.A. Jenkins, P.A. Perez-Mancera, D.J. Adams, D.A. Largaespada, L.F. Wessels, A.G. Rust, L.D. Stein, D.A. Tuveson, N.G. Copeland, E.A. Musgrove, A. Scarpa, J.R. Eshleman, T.J. Hudson, R.L. Sutherland, D.A. Wheeler, J.V. Pearson, J.D. McPherson, R.A. Gibbs, S.M. Grimmond, Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491, 399–405 (2012)
D.K. Chang, S.M. Grimmond, A.V. Biankin, Pancreatic cancer genomics. Curr. Opin. Genet. Dev. 24, 74–81 (2014)
T. Rausch, D.T. Jones, M. Zapatka, A.M. Stütz, T. Zichner, J. Weischenfeldt, N. Jäger, M. Remke, D. Shih, P.A. Northcott, E. Pfaff, J. Tica, Q. Wang, L. Massimi, H. Witt, S. Bender, S. Pleier, H. Cin, C. Hawkins, C. Beck, A. von Deimling, V. Hans, B. Brors, R. Eils, W. Scheurlen, J. Blake, V. Benes, A.E. Kulozik, O. Witt, D. Martin, C. Zhang, R. Porat, D.M. Merino, J. Wasserman, N. Jabado, A. Fontebasso, L. Bullinger, F.G. Rücker, K. Döhner, H. Döhner, J. Koster, J.J. Molenaar, R. Versteeg, M. Kool, U. Tabori, D. Malkin, A. Korshunov, M.D. Taylor, P. Lichter, S.M. Pfister, J.O. Korbel, Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59–71 (2012)
J. Weischenfeldt, R. Simon, L. Feuerbach, K. Schlangen, D. Weichenhan, S. Minner, D. Wuttig, H.J. Warnatz, H. Stehr, T. Rausch, N. Jäger, L. Gu, O. Bogatyrova, A.M. Stütz, R. Claus, J. Eils, R. Eils, C. Gerhäuser, P.H. Huang, B. Hutter, R. Kabbe, C. Lawerenz, S. Radomski, C.C. Bartholomae, M. Fälth, S. Gade, M. Schmidt, N. Amschler, T. Haß, R. Galal, J. Gjoni, R. Kuner, C. Baer, S. Masser, C. von Kalle, T. Zichner, V. Benes, B. Raeder, M. Mader, V. Amstislavskiy, M. Avci, H. Lehrach, D. Parkhomchuk, M. Sultan, L. Burkhardt, M. Graefen, H. Huland, M. Kluth, A. Krohn, H. Sirma, L. Stumm, S. Steurer, K. Grupp, H. Sültmann, G. Sauter, C. Plass, B. Brors, M.L. Yaspo, J.O. Korbel, T.T. Schlomm, Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159–170 (2013)
S. Babashah, M. Sadeghizadeh, M.R. Tavirani, S. Farivar, M. Soleimani, Aberrant microRNA expression and its implications in the pathogenesis of leukemias. Cell. Oncol. 35, 317–334 (2012)
M.F. Arteaga, J.H. Mikesch, J. Qiu, J. Christensen, K. Helin, S.C. Kogan, S. Dong, C.W.E. So, The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia. Cancer Cell 23, 376–389 (2013)
T.K. Fung, C.W.E. So, Overcoming treatment resistance in acute promyelocytic leukemia and beyond. Oncotarget 4, 1128–1129 (2013)
M.A. Dawson, R.K. Prinjha, A. Dittman, G. Giotopoulos, M. Bantscheff, W.I. Chan, S.C. Robson, C.W. Chung, C. Hopf, M.M. Savitski, C. Huthmacher, E. Gudgin, D. Lugo, S. Beinke, T.D. Chapman, E.J. Roberts, P.E. Soden, K.R. Auger, O. Mirguet, K. Doehner, R. Delwel, A.K. Burnett, P. Jeffrey, G. Drewes, K. Lee, B.J.P. Huntly, T. Kouzarides, Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529–533 (2013)
M.A. Dawson, E.J. Gudgin, S.J. Horton, G. Giotopoulos, E. Meduri, S. Robson, E. Cannizzaro, H. Osaki, M. Wiese, S. Putwain, C.Y. Fong, C. Grove, J. Craig, A. Dittmann, D. Lugo, P. Jeffrey, G. Drewes, K. Lee, L. Bullinger, R.K. Prinjha, T. Kouzarides, G.S. Vassiliou, B.J.P. Huntly, Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia. Leukemia 28, 311–320 (2014)
D. Sturm, S. Bender, D.T.W. Jones, P. Lichter, J. Grill, O. Becher, C. Hawkins, J. Majewski, C. Jones, J.F. Costello, A. Iavarone, K. Aldape, C.W. Brennan, N. Jabado, S.M. Pfister, Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge. Nature Rev. Cancer 14, 92–107 (2014)
A.M. Fontebasso, S. Papillon-Cavanagh, J. Schwartzentruber, H. Nikbakht, N. Gerges, P.O. Fiset, D. Bechet, D. Faury, N. De Jay, L.A. Ramkissoon, A. Corcoran, D.T.W. Jones, D. Sturm, P. Johann, T. Tomita, S. Goldman, M. Nagib, A. Bendel, L. Goumnerova, D.C. Bowers, J.R. Leonard, J.B. Rubin, T. Alden, S. Browd, J.R. Geyer, S. Leary, G. Jallo, K. Cohen, N. Gupta, M.D. Prados, A.S. Carret, B. Ellezam, L. Crevier, A. Klekner, L. Bognar, P. Hauser, M. Garami, J. Myseros, Z. Dong, P.M. Siegel, H. Malkin, A.H. Ligon, S. Albrecht, S.M. Pfister, K.L. Ligon, J. Majewski, N. Jabado, M.W. Kieran, Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nature Genet. 46, 462–466 (2014)
B.E. Johnson, T. Mazor, C. Hong, M. Barnes, K. Aihara, C.Y. McLean, S.D. Fouse, S. Yamamoto, H. Ueda, K. Tatsuno, S. Asthana, L.E. Jalbert, S.J. Nelson, A.W. Bollen, W.C. Gustafson, E. Charron, W.A. Weiss, I.V. Smirnov, J.S. Song, A.B. Olshen, S. Cha, Y. Zhao, R.A. Moore, A.J. Mungall, S.J.M. Jones, M. Hirst, M.A. Marra, N. Saito, H. Aburatani, A. Mukasa, M.S. Berger, S.M. Chang, B.S. Taylor, J.F. Costello, Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science 343, 189–193 (2014)
M.J. Jonker, J.P. Melis, J.R.V. Kuiper, T.V. van der Hoeven, P.F. Wackers, J. Robinson, G.T. van der Horst, M.E. Dollé, J. Vijg, T.M. Breit, J.H.J. Hoeijmakers, H. van Steeg, Life spanning murine gene expression profiles in relation to chronological and pathological aging in multiple organs. Aging Cell. 12, 901–909 (2013)
H. Lans, J.M. Lindvall, K. Thijssen, A.E. Karambelas, D. Cupac, Ø. Fensgard, G. Jansen, J.H.J. Hoeijmakers, H. Nilsen, W. Vermeulen, DNA damage leads to progressive replicative decline but extends the life span of long-lived mutant animals. Cell Death Diff. 20, 1709–1718 (2013)
S. Gravina, M.E.T. Dolle’, T. Wang, H. van Steeg, P. Hasty, J. Hoeijmakers, J. Vijg, High preservation of CpG cytosine methylation patterns at imprinted gene loci in liver and brain of aged mice. PLoS One 8, e73496 (2013)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Geurts van Kessel, A. The cancer genome: from structure to function. Cell Oncol. 37, 155–165 (2014). https://doi.org/10.1007/s13402-014-0177-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-014-0177-5